114 related articles for article (PubMed ID: 7388770)
1. Phase II trial of prednimustine, L-1031, (NSC-134087) in advanced breast cancer.
Mouridsen HT; Kristensen D; Nielsen JH; Dombernowsky P
Cancer; 1980 Jul; 46(2):253-5. PubMed ID: 7388770
[TBL] [Abstract][Full Text] [Related]
2. A phase III trial comparing prednimustine (LEO 1031) to chlorambucil plus prednisolone in advanced breast cancer.
Løber J; Mouridsen HT; Christiansen IE; Dombernowsky P; Mattsson W; Rørth M
Cancer; 1983 Nov; 52(9):1570-6. PubMed ID: 6352005
[TBL] [Abstract][Full Text] [Related]
3. A phase III study of prednimustine (LEO 1031) in advanced breast cancer. A preliminary report.
Rørth M; Løber J; Dombernowsky P; Krusenstjerna-Hofstrom D; Mattsson W; Mouridsen HT
Eur J Cancer (1965); 1980; Suppl 1():137-40. PubMed ID: 7032923
[No Abstract] [Full Text] [Related]
4. Prednimustine in advanced breast cancer: a review.
Mouridsen HT
Semin Oncol; 1986 Mar; 13(1 Suppl 1):27-31. PubMed ID: 3513318
[TBL] [Abstract][Full Text] [Related]
5. Prednimustine in combination with methotrexate and 5-FU (PMF): a pilot study.
Boesen E; Mouridsen HT
Cancer Treat Rep; 1982 Dec; 66(12):2081-3. PubMed ID: 7139649
[TBL] [Abstract][Full Text] [Related]
6. Prednimustine in refractory non-Hodgkin's lymphoma: a phase II study of the Northern California Oncology Group.
Gandara DR; Wold HG; Redmond J; Kohler M; Reynolds R; Wong P; Forsythe J; Fisher K; Lewis B
Semin Oncol; 1986 Mar; 13(1 Suppl 1):14-8. PubMed ID: 3952517
[TBL] [Abstract][Full Text] [Related]
7. Phase II trial of prednimustine as first-line chemotherapy in patients with advanced breast cancer.
Rankin EM; Harvey C; Knight RK; Rubens RD
Cancer Treat Rep; 1987 Nov; 71(11):1107-8. PubMed ID: 3119205
[No Abstract] [Full Text] [Related]
8. Phase II trial of prednimustine (NSC-134087) in the treatment of small-cell anaplastic carcinoma of the lung.
Jensen HS; Hansen HH; Dombernowsky P
Cancer Chemother Pharmacol; 1980; 4(4):259-61. PubMed ID: 6254684
[TBL] [Abstract][Full Text] [Related]
9. Phase II trial of prednimustine in glioblastoma multiforme.
Andersen J; Christensen L; Kongsholm H
Cancer Treat Rep; 1984 May; 68(5):795-7. PubMed ID: 6327038
[TBL] [Abstract][Full Text] [Related]
10. Prednimustine for prostate cancer therapy.
Slack NH; Murphy GP
Compr Ther; 1979 Sep; 5(9):54-7. PubMed ID: 487742
[No Abstract] [Full Text] [Related]
11. Prednimustine combined with mitoxantrone and 5-fluorouracil for first and second-line chemotherapy in advanced breast cancer.
Samonigg H; Stöger H; Kasparek AK; Schmid M; Dusleag J; Pfeiffer K; Smola M; Steindorfer P; Lechner P
Cancer Chemother Pharmacol; 1991; 27(6):477-80. PubMed ID: 2013118
[TBL] [Abstract][Full Text] [Related]
12. Clinical trial of prednimustine, Leo-1031 (NSC-134087), in patients with non-Hodgkin lymphomata and chronic lymphocytic leukaemia previously treated with steroids and alkylating agents.
Pedersen-Bjergaard J; Hansen MM; Geisler CH; Nissen NI
Acta Med Scand; 1980; 207(3):215-20. PubMed ID: 6989170
[TBL] [Abstract][Full Text] [Related]
13. Prednimustine in advanced malignant melanoma: a phase II study.
Pedersen L; Løber J; Dalmark M; Mouridsen HT
Cancer Treat Rep; 1987 Dec; 71(12):1315-6. PubMed ID: 3690549
[No Abstract] [Full Text] [Related]
14. Treatment of refractory chronic lymphocytic leukemia with prednimustine: a phase II study using strict response criteria.
Gandara DR; George CB; Ries CA; Koretz MM; Lewis JP
Cancer Chemother Pharmacol; 1987; 19(2):165-8. PubMed ID: 3568275
[TBL] [Abstract][Full Text] [Related]
15. Phase II trial of Prednimustine. Leo-1031 (NSC-134087) in acute non-lymphocytic leukemia.
Juul K; Sørensen P; Pedersen-Bjergaard J; Jensen MK
Scand J Haematol; 1979 Nov; 23(5):388-92. PubMed ID: 396664
[TBL] [Abstract][Full Text] [Related]
16. Premarin priming before prednimustine, high-dose folinic acid and 5-fluorouracil as salvage chemotherapy for advanced breast cancer.
Marini G; Simoncini E; Marpicati P; Montini E; Ferrari V; Arcangeli G; Zaniboni A
Chemioterapia; 1988 Apr; 7(2):130-2. PubMed ID: 2840216
[TBL] [Abstract][Full Text] [Related]
17. Prednimustine in combination with methotrexate and 5-fluorouracil in advanced breast cancer: a phase I-II study.
Mouridsen HT; Boesen E
Breast Cancer Res Treat; 1983; 3(1):85-9. PubMed ID: 6871484
[TBL] [Abstract][Full Text] [Related]
18. Randomised trial comparing prednimustine with combination chemotherapy in advanced ovarian carcinoma.
Leonard RC; Smart GE; Livingstone JR; Cornbleet MA; Kerr GR; Fletcher S; Webb JN; Smyth JF
Cancer Chemother Pharmacol; 1989; 23(2):105-10. PubMed ID: 2491962
[TBL] [Abstract][Full Text] [Related]
19. Prednimustine in adult acute myeloid leukaemia.
Brandt L; Könyves I
Cancer Chemother Pharmacol; 1979; 2(2):133-6. PubMed ID: 394873
[TBL] [Abstract][Full Text] [Related]
20. A phase II study of prednimustine in acute non-lymphocytic leukemia, smouldering leukemia, and refractory anemia with excess blasts.
Gandara DR; Ries CA; Schiff SA; George CB; Lewis JP; Koretz MM; Carter SK
Cancer Chemother Pharmacol; 1982; 9(1):10-2. PubMed ID: 7139848
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
